Moody's, Medco: New Targets, Estimates
Also see: Goldman Sachs, eBay: Analysts' New Ratings
Editor's Note: Green and red arrows refer to intraday stock price movement.
NEW YORK (
) --
STOCK COMMENTS / EPS CHANGES
Cerner
(CERN) - Get Free Report
added to Top Picks List at FBR Capital Markets. Company can continue to deliver solid growth in the current environment.
CVS Caremark
(CVS) - Get Free Report
price target boosted at Citi to $46 from $41. CVS has been awarded a three-year contract to provide integrated PBM services for Federal Employee Program, Citigroup said.
Johnson & Johnson
(JNJ) - Get Free Report
price target higher at Citi by a dollar to $71. JNJ's overhaul of its Pharma division 10 years ago hit its stride this year, seeing fundamental turn, Citigroup said. Maintain Buy rating.
Moody's
(MCO) - Get Free Report
estimates, target upped at Benchmark. MCO estimates were boosted through 2012, Benchmark said. Company should benefit from better investment-grade issuance. Overweight rating and new $45 price target.
MGM Resorts
(MGM) - Get Free Report
numbers boosted at Jefferies. Shares of MGM now seen reaching $19, according to Jefferies. Estimates also upped, given better trends in Macau and Singapore. Buy rating.
Medco Health
(MHS)
cut from Top Picks List at FBR Capital Markets. Company lost $3 billion annual contract to CVS. Target also lowered to $71.
Nextera Energy
(NEE) - Get Free Report
numbers increased at Goldman. NEE estimates were raised through 2014. Company should see higher earnings at its regulated assets. Neutral rating and new $58 price target.
Vale
(VALE) - Get Free Report
estimates, target raised at Goldman. Shares of VALE now seen reaching $44. Estimates also increased, as iron ore prices should benefit from lower supply. Buy rating.
End of report.
This article was written by a staff member of TheStreet.
